L-Cycloserine
- Generic Name
- L-Cycloserine
- Brand Names
- Seromycin
- Drug Type
- Small Molecule
- Chemical Formula
- C3H6N2O2
- CAS Number
- 339-72-0
- Unique Ingredient Identifier
- AK7DRB7FMO
- Background
Antibiotic substance produced by Streptomyces garyphalus.
- Indication
本品与其他抗结核药联合，用于经一线药物（如吡嗪酰胺、链霉素、异烟肼、利福平和乙胺丁醇）治疗失败的患者。本品还可用于治疗非结核分枝杆菌感染如鸟复合分枝杆菌病的治疗。
- Associated Conditions
- Pulmonary Tuberculosis (TB), Tuberculosis, Extrapulmonary, Grade 1, grade 2, grade 3, grade 4 Urinary Tract Infection
- Associated Therapies
- -
Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2012-07-16
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 33
- Registration Number
- NCT00182000
Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder
- Conditions
- First Posted Date
- 2005-08-18
- Last Posted Date
- 2009-08-26
- Lead Sponsor
- Hartford Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00131339
- Locations
- 🇺🇸
Center for Anxiety and Related Disorders at Boston University, Boston, Massachusetts, United States
🇺🇸Hartford Hospital, Hartford, Connecticut, United States
Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia
- Conditions
- Interventions
- First Posted Date
- 2005-08-09
- Last Posted Date
- 2014-05-20
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 48
- Registration Number
- NCT00128401
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder
- Conditions
- First Posted Date
- 2005-08-03
- Last Posted Date
- 2009-07-29
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT00126282
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Anxiety Disorders Center, The Institute of Living, Hartford, Connecticut, United States
D-cycloserine in the Management of Chronic Low Back Pain
- First Posted Date
- 2005-08-01
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Thomas J. Schnitzer
- Target Recruit Count
- 41
- Registration Number
- NCT00125528
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 525
- Registration Number
- NCT00000796
- Locations
- 🇺🇸
Montefiore Drug Treatment Ctr / Bronx Municipal Hosp, Bronx, New York, United States
🇺🇸Cook County Hosp, Chicago, Illinois, United States
🇺🇸Bronx Lebanon Hosp Ctr, Bronx, New York, United States
Trial of D-Cycloserine in Schizophrenia
- First Posted Date
- 1999-11-03
- Last Posted Date
- 2014-09-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT00000371
Glycine and D-Cycloserine in Schizophrenia
- Conditions
- Interventions
- First Posted Date
- 1999-11-03
- Last Posted Date
- 2014-06-12
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT00000372
- Locations
- 🇺🇸
Freedom Trail Clinic, Boston, Massachusetts, United States
Neurobiology of Opioid Dependence: 3 - 3
- Conditions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2016-05-06
- Lead Sponsor
- Yale University
- Registration Number
- NCT00000194
- Locations
- 🇺🇸
VA Connecticut Healthcare System, New Haven, Connecticut, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.